case_images: PMC5566369_01
case_images: Diffuse vitreous opacity at the time of admission.
case_images: imcrj-10-279Fig1.jpg
case_images: PMC5566369_01_imcrj-10-279Fig1.jpg
case_images: f1-imcrj-10-279
case_images: We continued administering topical levofloxacin accompanied with intravitreal vancomycin (1 mg/0.1 mL) and amikacin (0.4 mg/0.1 mL) injection every 2 days without systemic antibiotic therapy, but hypopyon remained and vitreous opacity was found by B-scan ultrasonography (Figure 1).
case_images: External appearance of the eye with severe chemosis and hyperemia (A) and vitreous opacity (B) observed intraoperatively.
case_images: imcrj-10-279Fig2.jpg
case_images: PMC5566369_01_imcrj-10-279Fig2.jpg
case_images: f2-imcrj-10-279
case_images: Diffuse vitreous haze without vitreous hemorrhage or retinal break was found during TPPV (Figure 2), and the vitreous cavity was cleared by vitrectomy and examined by indirect ophthalmoscope to ensure media clarity.
case_images: Color fundus photography without vitreous opacity after the secondary discharge.
case_images: imcrj-10-279Fig3.jpg
case_images: PMC5566369_01_imcrj-10-279Fig3.jpg
case_images: f3-imcrj-10-279
case_images: The vitreous opacity had vanished postoperatively, and the patient was discharged on October 29, 2015 (Figure 3).
case_images: Clear external eye appearance without significant lesion at the last visit.
case_images: imcrj-10-279Fig4.jpg
case_images: PMC5566369_01_imcrj-10-279Fig4.jpg
case_images: f4-imcrj-10-279
case_images: The anterior chamber cell had diminished to a score of zero, and the BCVA recovered to 20/32 at the last visit on January 20, 2017 (Figure 4).